Procurement Summary
Country: Argentina
Summary: Acquisition of Medications Include Health
Deadline: 23 Apr 2026
Posting Date: 18 Apr 2026
Other Information
Notice Type: Tender
TOT Ref.No.: 139735519
Document Ref. No.: 401-0551-LPU26
Competition: NCB
Financier: Self Financed
Purchaser Ownership: Public
Tender Value: ARS 524019026.88
Purchaser's Detail
Name: Login to see tender_details
Address: Login to see tender_details
Email: Login to see tender_details
Login to see detailsTender Details
FLUTICASONE FUROATE + VILANTEROL. Model: 92 mcg of fluticasone furoate + 22 mcg of vilanterol. Powder for inhalation, LEVETIRACETAM. Model: 100 mg/ml, oral solution, SULTIAMO. Model: 50 mg, tablet, TIOTROPIO. Model: 18 µg (as Bromide), powder for inhalation, in hard capsule, UMECLIDINIUM + VILANTEROL. Model: 55 mcg of Umeclidinium + 22 mcg of vilanterol, powder for inhalation, CINACALCET. Model: In tablet, EPLERENONE. Model: 25 mg. Coated tablet.
File number: EX-2026-15982278- -GCABA-DGACSA Legal framework: Law No. 2, 095 (Consolidated Text by Law No. 6, 588) and Decree No. 129/23 Art. 32 Other conditions: Requires technical advice Responsible area: Technical Support Operational Deputy Manager More info: Place of receipt of physical documentation: Rivadavia 524, 4th floor, DGACSA Office
Documents
Tender Notice